{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T15:55:26Z","timestamp":1758124526240},"reference-count":0,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2016,1,4]],"date-time":"2016-01-04T00:00:00Z","timestamp":1451865600000},"content-version":"vor","delay-in-days":17230,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Pharma and Therapeutics"],"published-print":{"date-parts":[[1968,11]]},"abstract":"<jats:p>Liver function tests were performed on 20 human volunteers before, during, and after the long\u2010term administration of morphine. No significant differences in the serum glutamic\u2010oxaloacetic tramaminase, serum glutamic\u2010pyruvic tramminase, thymol turbidity, or cephalin flocculation were found. It is concluded that the high incidence of abnormal liver function tests observed in morphine and heroin addicts is not due to a direct hepatotoxic effect of the drug.<\/jats:p>","DOI":"10.1002\/cpt196896720","type":"journal-article","created":{"date-parts":[[2016,1,5]],"date-time":"2016-01-05T00:55:26Z","timestamp":1451955326000},"page":"720-724","source":"Crossref","is-referenced-by-count":31,"title":["Liver disease in narcotic addicts I. The role of the drug"],"prefix":"10.1111","volume":"9","author":[{"given":"C. W.","family":"Gorodetzky","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. D.","family":"Sapira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D. R.","family":"Jasinski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W. R.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2016,1,4]]},"container-title":["Clinical Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fcpt196896720","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fcpt196896720","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/ascpt.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/cpt196896720","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,7]],"date-time":"2023-11-07T13:28:23Z","timestamp":1699363703000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascpt.onlinelibrary.wiley.com\/doi\/10.1002\/cpt196896720"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1968,11]]},"references-count":0,"journal-issue":{"issue":"6","published-print":{"date-parts":[[1968,11]]}},"alternative-id":["10.1002\/cpt196896720"],"URL":"https:\/\/doi.org\/10.1002\/cpt196896720","archive":["Portico"],"relation":{},"ISSN":["0009-9236","1532-6535"],"issn-type":[{"value":"0009-9236","type":"print"},{"value":"1532-6535","type":"electronic"}],"subject":[],"published":{"date-parts":[[1968,11]]}}}